What is Upheal?
Based in Prague, Upheal is at the forefront of leveraging artificial intelligence to enhance mental healthcare delivery. The platform is designed to assist therapists by automating and streamlining administrative tasks, such as the creation of progress notes and treatment plans. This focus on workflow optimization aims to free up clinicians' time, allowing them to dedicate more resources to patient care and therapeutic interventions. Upheal's innovative approach positions it as a key player in the rapidly evolving HealthTech landscape, addressing the critical need for efficient and effective mental health support systems.
How much funding has Upheal raised?
Upheal has raised a total of $14.3M across 3 funding rounds:
Other Financing Round
$1M
Angel/Seed
$3.3M
Series A
$10M
Other Financing Round (2022): $1M with participation from Calm/Storm Ventures, Juraj Masar, Kaya Vc, and Credo Ventures
Angel/Seed (2024): $3.3M led by Kaya Vc, Credo Ventures, and Inovia
Series A (2024): $10M supported by Kaya Ventures, Credo Ventures, and Headline
Key Investors in Upheal
Headline
Headline is a venture capital firm that partners with fast-growing technology teams globally, investing from Series B and beyond to facilitate international success.
Kaya Vc
Kaya Vc is a venture capital firm based in Prague, Czech Republic, operating within the Venture Capital & Private Equity industry.
Credo Ventures
Credo Ventures supports exceptional technology founders from Central and Eastern Europe with global ambitions, focusing on pre-seed and seed stage companies.
What's next for Upheal?
With the recent major strategic investment, Upheal is poised for accelerated expansion and further development of its AI-driven mental health solutions. The substantial capital infusion, coupled with the company's established track record of securing funding, suggests a strategic focus on enhancing its platform capabilities, expanding its market reach, and potentially exploring new therapeutic areas or service offerings. The involvement of prominent investors in this latest round indicates a strong belief in Upheal's business model and its capacity to disrupt the traditional mental healthcare industry. Future endeavors will likely involve scaling its operations, strengthening its technological infrastructure, and solidifying its position as a leader in AI-powered clinical support.
See full Upheal company page
